{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T02:09:00Z","timestamp":1777774140840,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81630091"],"award-info":[{"award-number":["81630091"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2016CFA018"],"award-info":[{"award-number":["2016CFA018"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2016YFE0122800"],"award-info":[{"award-number":["2016YFE0122800"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32170519"],"award-info":[{"award-number":["32170519"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013317","name":"Shanxi Provincial Key Research and Development Project","doi-asserted-by":"publisher","award":["2016YFE0122800"],"award-info":[{"award-number":["2016YFE0122800"]}],"id":[{"id":"10.13039\/501100013317","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ijbiomac.2026.150379","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T07:21:34Z","timestamp":1768807294000},"page":"150379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["Peptide\u2011potassium channel interaction law-guided design of Kv1.3 channel-selective peptide immunosuppressants"],"prefix":"10.1016","volume":"341","author":[{"given":"Yonghui","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenhu","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zongyun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijian","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingliang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ijbiomac.2026.150379_bb0005","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.autrev.2012.02.001","article-title":"Updated assessment of the prevalence, spectrum and case definition of autoimmune disease","volume":"11","author":"Hayter","year":"2012","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.150379_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103236","article-title":"Autoimmune pre-disease","volume":"22","author":"Bieber","year":"2023","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150379_bb0015","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1600-065X.2009.00816.x","article-title":"The functional network of ion channels in T lymphocytes","volume":"231","author":"Cahalan","year":"2009","journal-title":"Immunol. Rev."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.150379_bb0020","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1096\/fj.14-251967","article-title":"Kv1.3 channel-blocking immunomodulatory peptides from parasitic worms: implications for autoimmune diseases","volume":"28","author":"Chhabra","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.ijbiomac.2026.150379_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.714841","article-title":"Kv1.3 channel up-regulation in peripheral blood T lymphocytes of patients with multiple sclerosis","volume":"12","author":"Markakis","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.150379_bb0030","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1080\/14712598.2017.1346606","article-title":"Treating autoimmune disorders with venom-derived peptides","volume":"17","author":"Shen","year":"2017","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.ijbiomac.2026.150379_bb0035","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/164_2021_502","article-title":"Pharmacological approaches to studying potassium channels","volume":"267","author":"Mathie","year":"2021","journal-title":"Handb. Exp. Pharmacol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.150379_bb0040","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2211977120","article-title":"A bioengineered probiotic for the oral delivery of a peptide Kv1.3 channel blocker to treat rheumatoid arthritis","volume":"120","author":"Wang","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.150379_bb0045","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1124\/mol.105.015669","article-title":"Design of PAP-1, a selective small molecule Kv1.3 blocker, for the suppression of effector memory T cells in autoimmune diseases","volume":"68","author":"Schmitz","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2026.150379_bb0050","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaut.2014.07.003","article-title":"Kv1.3 in psoriatic disease: PAP-1, a small molecule inhibitor of Kv1.3 is effective in the SCID mouse psoriasis--xenograft model","volume":"55","author":"Kundu-Raychaudhuri","year":"2014","journal-title":"J. Autoimmun."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.150379_bb0055","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1038\/sj.bjp.0702480","article-title":"UK-78,282, a novel piperidine compound that potently blocks the Kv1.3 voltage-gated potassium channel and inhibits human T cell activation","volume":"126","author":"Hanson","year":"1999","journal-title":"Br. J. Pharmacol."},{"issue":"24","key":"10.1016\/j.ijbiomac.2026.150379_bb0060","doi-asserted-by":"crossref","first-page":"7781","DOI":"10.1021\/bi025722c","article-title":"Identification of a new class of inhibitors of the voltage-gated potassium channel, Kv1.3, with immunosuppressant properties","volume":"41","author":"Schmalhofer","year":"2002","journal-title":"Biochemistry"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.150379_bb0065","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1124\/mol.65.6.1364","article-title":"Kv1.3-blocking 5-phenylalkoxypsoralens: a new class of immunomodulators","volume":"65","author":"Vennekamp","year":"2004","journal-title":"Mol. Pharmacol."},{"issue":"24","key":"10.1016\/j.ijbiomac.2026.150379_bb0070","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.2174\/138161208785777441","article-title":"Animal toxins acting on voltage-gated potassium channels","volume":"14","author":"Mouhat","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ijbiomac.2026.150379_bb0075","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1038\/ncomms3602","article-title":"The genome of Mesobuthus martensii reveals a unique adaptation model of arthropods","volume":"4","author":"Cao","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2026.150379_bb0080","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/164_2021_500","article-title":"Peptide Toxins Targeting Kv Channels","volume":"267","author":"Matsumura","year":"2021","journal-title":"Handb. Exp. Pharmacol."},{"issue":"33","key":"10.1016\/j.ijbiomac.2026.150379_bb0085","doi-asserted-by":"crossref","first-page":"22704","DOI":"10.1074\/jbc.M114.568642","article-title":"Targeting the ion channel Kv1.3 with scorpion venom peptides engineered for potency, selectivity, and half-life","volume":"289","author":"Edwards","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.150379_bb0090","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1002\/med.21800","article-title":"Discovery of K(V) 1.3 ion channel inhibitors: medicinal chemistry approaches and challenges","volume":"41","author":"Gubic","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ijbiomac.2026.150379_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114146","article-title":"The voltage-gated potassium channel Kv1.3 as a therapeutic target for venom-derived peptides","volume":"181","author":"Tajti","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.150379_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180762","article-title":"Safety and pharmacodynamics of dalazatide, a Kv1.3 channel inhibitor, in the treatment of plaque psoriasis: a randomized phase 1b trial","volume":"12","author":"Tarcha","year":"2017","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.150379_bb0105","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41573-019-0013-8","article-title":"Antibodies and venom peptides: new modalities for ion channels","volume":"18","author":"Wulff","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.150379_bb0110","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.toxicon.2011.07.016","article-title":"Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases","volume":"59","author":"Chi","year":"2012","journal-title":"Toxicon"},{"issue":"29","key":"10.1016\/j.ijbiomac.2026.150379_bb0115","doi-asserted-by":"crossref","first-page":"27093","DOI":"10.1074\/jbc.M413626200","article-title":"A variable residue in the pore of Kv1 channels is critical for the high affinity of blockers from sea anemones and scorpions","volume":"280","author":"Gilquin","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2026.150379_bb0120","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.neuropharm.2018.09.030","article-title":"Kv1.2 channel-specific blocker from Mesobuthus eupeus scorpion venom: structural basis of selectivity","volume":"143","author":"Kuzmenkov","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ijbiomac.2026.150379_bb0125","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijbiomac.2021.02.155","article-title":"Different pharmacological properties between scorpion toxin BmKcug2 and its degraded analogs highlight the diversity of K+ channel blockers from thermally processed scorpions","volume":"178","author":"Qin","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.150379_bb0130","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2113536119","article-title":"Rearrangement of a unique Kv1.3 selectivity filter conformation upon binding of a drug","volume":"119","author":"Tyagi","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.150379_bb0135","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.1021\/pr800494a","article-title":"Different residues in channel turret determining the selectivity of ADWX-1 inhibitor peptide between Kv1.1 and Kv1.3 channels","volume":"7","author":"Yin","year":"2008","journal-title":"J. Proteome Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150379_bb0140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/2666121701999200531143349","article-title":"Scorpion Toxin-Potassium Channel interaction law and its applications","volume":"1","author":"Zuo","year":"2021","journal-title":"Venoms and Toxins"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.150379_bb0145","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1021\/pr100027k","article-title":"Protein-protein recognition control by modulating electrostatic interactions","volume":"9","author":"Han","year":"2010","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.ijbiomac.2026.150379_bb0150","doi-asserted-by":"crossref","first-page":"9881","DOI":"10.1038\/srep09881","article-title":"Toxin acidic residue evolutionary function-guided design of de novo peptide drugs for the immunotherapeutic target, the Kv1.3 channel","volume":"5","author":"Chen","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2026.150379_bb0155","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.toxicon.2014.05.002","article-title":"Margatoxin is a non-selective inhibitor of human Kv1.3 K+ channels","volume":"87","author":"Bartok","year":"2014","journal-title":"Toxicon"},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.150379_bb0160","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.bcp.2008.08.018","article-title":"A selective blocker of Kv1.2 and Kv1.3 potassium channels from the venom of the scorpion Centruroides suffusus suffusus","volume":"76","author":"Corzo","year":"2008","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150379_bb0165","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbrc.2014.03.101","article-title":"Unusual binding mode of scorpion toxin BmKTX onto potassium channels relies on its distribution of acidic residues","volume":"447","author":"Chen","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"27","key":"10.1016\/j.ijbiomac.2026.150379_bb0170","doi-asserted-by":"crossref","first-page":"19058","DOI":"10.1074\/jbc.M802054200","article-title":"Structural basis of a potent peptide inhibitor designed for Kv1.3 channel, a therapeutic target of autoimmune disease","volume":"283","author":"Han","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2026.150379_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.648408","article-title":"Low-dose IL-2 therapy in autoimmune and rheumatic diseases","volume":"12","author":"Grasshoff","year":"2021","journal-title":"Front. Immunol."},{"issue":"22","key":"10.1016\/j.ijbiomac.2026.150379_bb0180","doi-asserted-by":"crossref","first-page":"6834","DOI":"10.1021\/bi00188a012","article-title":"Purification and characterization of three inhibitors of voltage-dependent K+ channels from Leiurus quinquestriatus var. hebraeus venom","volume":"33","author":"Garcia","year":"1994","journal-title":"Biochemistry"},{"issue":"Pt 1","key":"10.1016\/j.ijbiomac.2026.150379_bb0185","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1042\/BJ20041379","article-title":"K+ channel types targeted by synthetic OSK1, a toxin from Orthochirus scrobiculosus scorpion venom","volume":"385","author":"Mouhat","year":"2005","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.150379_bb0190","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1124\/mol.112.078006","article-title":"Vm24, a natural immunosuppressive peptide, potently and selectively blocks Kv1.3 potassium channels of human T cells","volume":"82","author":"Varga","year":"2012","journal-title":"Mol. Pharmacol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026003053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026003053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T17:37:55Z","timestamp":1777484275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026003053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":38,"alternative-id":["S0141813026003053"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.150379","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peptide\u2011potassium channel interaction law-guided design of Kv1.3 channel-selective peptide immunosuppressants","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.150379","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"150379"}}